IHC was performed on a breast cancer tumor microarray (BR1141A; tissuearray.com). Antibodies used for IHC include pHSF1 (S326; Abcam #76076; RRID: AB_1310328), CD3 (Santa Cruz Biotechnology #sc-20047; RRID: AB_627014), CD8A (CST #85336; RRID: AB_2800052), and CCL5 (Invitrogen #710001; RRID: AB_2532515). IHC was performed by deparaffinization using xylenes followed by rehydration with decreasing alcohol solutions. Slides were then incubated in Bloxall (Vector Laboratories #SP-6000–100) and subjected to antigen retrieval with 10 mmol/L citrate solution in a heated pressure cooker (2,100 Antigen Retriever; Aptum Biologics). Tissues were blocked in animal-free blocker (Vector Laboratories #SP-5035) and incubated in primary antibodies overnight in a humidified chamber. Primary antibodies were detected using Vectastain ABC-HRP kits (Rabbit: PK-4001; Mouse: PK-4010) and developed with DAB Immpact kit (Vector Laboratories #SK-4105) followed by dehydration with increasing alcohol solutions and mounted. Slides were imaged with Motic EasyScan scanner and analyzed with QuPath software (27 (link)).